Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silibinin Capsules (Shui Linjia) for prevention of anti-tuberculosis drug-induced liver injury
ChiCTR-TRC-14004857Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of silibinin in pulmonary tuberculosis (TB) (2 arms), sponsored by Tongji Hospital. Primary endpoints: Alanine aminotransferase, Aspartate aminotransferase and 8 more. Started Nov 2012; status: completed.
02
Drugs
silibinin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR-TRC-14004857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004857.